v3.26.1
Commitments and Contingencies - Additional Information (Details)
€ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 16, 2022
USD ($)
Mar. 31, 2026
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2022
USD ($)
Jan. 31, 2022
USD ($)
Jul. 31, 2019
USD ($)
Dec. 31, 2014
USD ($)
LicensedProduct
Jan. 31, 2014
USD ($)
Sep. 30, 2013
USD ($)
Jul. 31, 2011
USD ($)
Nov. 30, 2009
EUR (€)
Jun. 30, 2026
USD ($)
OperatingLease
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
OperatingLease
Jun. 30, 2025
USD ($)
Lessee Lease Description [Line Items]                              
Estimated payments due                       $ 22,665,000   $ 22,665,000  
Research and development expenses                       $ 30,749,000 $ 22,882,000 58,709,000 $ 46,225,000
National Institute of Health                              
Lessee Lease Description [Line Items]                              
License issue royalty fee                 $ 100,000            
Sales milestone payments                 600,000            
Development and regulatory milestone payments                 $ 700,000            
Patent licensing reimbursement fees                           30,000.00  
Expenses for patent licensing fees                           0 0
Royalty Bearing Patent License Agreement                              
Lessee Lease Description [Line Items]                              
Expenses                           0 0
License agreement term                     10 years        
Royalty Bearing Patent License Agreement | IND Filings                              
Lessee Lease Description [Line Items]                              
Potential milestone payments | €                     € 10        
Clearside                              
Lessee Lease Description [Line Items]                              
Expenses                           1,000,000 0
Upfront payment   $ 1,000,000       $ 100,000                  
One-time Payment   $ 1,500,000                          
Royalties on net sales           20.00%                  
License agreement expiration period           10 years                  
Clearside | Maximum                              
Lessee Lease Description [Line Items]                              
Aggregate milestones payment           $ 21,000,000                  
LI-COR, Inc. | 2014 Exclusive Agreement                              
Lessee Lease Description [Line Items]                              
One-time upfront license issuance fee               $ 100,000              
Research and development expenses                           0 0
License agreement expiration period               10 years              
LI-COR, Inc. | 2014 Exclusive Agreement | Maximum                              
Lessee Lease Description [Line Items]                              
Aggregate milestone payments               $ 200,000              
LI-COR, Inc. | 2014 Non- Exclusive Agreement                              
Lessee Lease Description [Line Items]                              
License issue fee             $ 30,000.00                
Milestone payments                           0 0
LI-COR, Inc. | 2014 Non- Exclusive Agreement | Maximum                              
Lessee Lease Description [Line Items]                              
Payments for development and commercial milestones             $ 400,000                
Life Technologies                              
Lessee Lease Description [Line Items]                              
Milestone payments                           0 0
Number of licensed products | LicensedProduct             5                
Initial license fee             $ 100,000                
Initial license fee for first licensed product       $ 400,000                      
Initial license fee for additional licensed product       500,000                      
Payment for sublicense       200,000                      
Payment for use of cell line document package       30,000.00                      
Annual development fee             100,000                
Non-refundable, Non- creditable fee             300,000                
Change of control fees       $ 500,000     200,000                
One time perpetual license agreement fee         $ 50,000.00                    
Expense related to agreement including sublicense                           0 0
Dr. John Schiller | 2014 Non- Exclusive Agreement                              
Lessee Lease Description [Line Items]                              
Required amendment payment     $ 60,000.00                        
Required amendment payment due period     30 days                        
Dr. John Schiller | Collaboration Research and Development Agreement                              
Lessee Lease Description [Line Items]                              
Annual development fee                   $ 30,000.00          
Agreement term                   2 years          
First payment due                   30 days          
Subsequent payments due                   30 days          
Research collaboration fees                           0 0
Dr. John Schiller | Collaboration Research and Development Agreement | 10th Anniversary                              
Lessee Lease Description [Line Items]                              
Required amendment payment     $ 50,000.00                        
Required amendment payment due period     30 days                        
Dr. John Schiller | Collaboration Research and Development Agreement | Ninth Amendment                              
Lessee Lease Description [Line Items]                              
Expenses                           $ 0 $ 0
Rakuten | 2014 Non- Exclusive Agreement                              
Lessee Lease Description [Line Items]                              
License issue fee             30,000.00                
Rakuten | 2014 Non- Exclusive Agreement | Maximum                              
Lessee Lease Description [Line Items]                              
License issue fee             $ 300,000                
Office and Laboratory Facility                              
Lessee Lease Description [Line Items]                              
Number of operating lease | OperatingLease                       1   1  
Estimated payments due $ 35,200,000                            
Lease commencement date Aug. 01, 2022                            
Operating lease, option to extend term 7 years                            
Letters of credit $ 800,000